Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Borgeson Blake Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.2907, valued at $64.8k
10/03/2023 144 Form 144 - Report of proposed sale of securities:
08/24/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.9118, valued at $79.2k
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 14,498 shares @ $11.0255, valued at $159.8k
Sold 3,272 shares @ $11.7468, valued at $38.4k
08/08/2023 144 Form 144 - Report of proposed sale of securities:
07/27/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Gifted 14,000 shares @ $0
Sold 18,719 shares @ $14.6089, valued at $273.5k
07/25/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $6.8873, valued at $61.2k
07/11/2023 144 Form 144 - Report of proposed sale of securities:
06/29/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.3876, valued at $65.6k
06/15/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 15,485 shares @ $9.9778, valued at $154.5k
06/01/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.7939, valued at $78.1k
05/30/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $5.0918, valued at $45.2k
05/16/2023 144 Form 144 - Report of proposed sale of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 144 Form 144 - Report of proposed sale of securities:
04/04/2023 144 Form 144 - Report of proposed sale of securities:
03/23/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.3994, valued at $65.7k
03/09/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.3274, valued at $74k
02/23/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.733, valued at $68.7k
02/09/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.8084, valued at $78.3k
01/26/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.7077, valued at $77.4k
01/12/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.6852, valued at $68.3k
01/05/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 1,325 shares @ $0
12/29/2022 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.2451, valued at $64.4k
12/15/2022 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.9587, valued at $79.6k
12/01/2022 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.7547, valued at $77.8k
11/18/2022 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 17,770 shares @ $11.1204, valued at $197.6k
10/05/2022 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 920 shares @ $0
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 1,300 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy